Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis

Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis

Abstract Background Pneumococcal disease, caused by Streptococcus pneumoniae, imposes a significant global health burden, particularly affecting vulnerable groups such as the elderly and immunocompromised. The 23-valent pneumococcal polysaccharide vaccine (PPV23) is designed to protect against 23 se...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammed Shabil, Shilpa Gaidhane, Suhas Ballal, Sanjay Kumar, Mahakshit Bhat, Shilpa Sharma, M. Ravi Kumar, Sarvesh Rustagi, Mahalaqua Nazli Khatib, Nishant Rai, Sanjit Sah, Edward Mawejje, Ganesh Bushi, Kiran Bhopte, Rachna Kathuria, Ambanna Yappalparvi
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Pneumonia
Subjects:
Pneumonia
PPV23
Vaccination
Meta-analysis
Mortality
Online Access:https://doi.org/10.1186/s41479-024-00149-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s41479-024-00149-5

Similar Items